• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响肺腺癌活检标本与手术切除标本组织学亚型诊断一致性的因素。

Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.

作者信息

Matsuzawa Reiko, Kirita Keisuke, Kuwata Takeshi, Umemura Shigeki, Matsumoto Shingo, Fujii Satoshi, Yoh Kiyotaka, Kojima Motohiro, Niho Seiji, Ohmatsu Hironobu, Ochiai Atsushi, Tsuboi Masahiro, Goto Koichi, Ishii Genichiro

机构信息

Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Japan; Department of Thoracic Oncology, National Cancer Center Hospital East, Japan.

Department of Thoracic Oncology, National Cancer Center Hospital East, Japan.

出版信息

Lung Cancer. 2016 Apr;94:1-6. doi: 10.1016/j.lungcan.2016.01.009. Epub 2016 Jan 22.

DOI:10.1016/j.lungcan.2016.01.009
PMID:26973199
Abstract

OBJECTIVES

Lung adenocarcinoma is heterogeneous, characterized by various histological subtypes. Determination of the predominant histological subtype (lepidic, papillary, acinar or solid-predominant) has been shown to correlate with genetic abnormalities and clinicopathological features. Although subtyping using small biopsy samples is important for tailored approaches to clinical management, limited data exist on the concordance of predominant subtype between resected specimens and biopsy specimens.

MATERIALS AND METHODS

We compared the diagnosed predominant subtypes in resected specimens and matched biopsy specimens in a series of 327 lung adenocarcinomas. The accuracy of preoperative diagnosis by biopsy and the factors that influence concordance with resected specimen analysis were examined.

RESULTS

In 211 of the 326 patients (66.0%), the predominant adenocarcinoma subtype diagnosed from biopsy matched the findings of resection analysis. Overall, the concordance rate in biopsy samples with larger tumor areas (≥ 0.7 mm(2)) was significantly higher than in those with smaller tumor area (<0.7 mm(2); 71.2% vs 60.7%, respectively; p=0.015). In the biopsy samples with smaller tumor areas, the concordance rate was 77% in lepidic subtype, 71% in papillary subtype, 60% in solid subtype, and 40% in acinar subtype. Concordance rate in the biopsy samples with larger tumor area was higher in papillary and solid subtypes (88% and 76%, respectively), but remained low in acinar subtype (37%).

CONCLUSION

The current results indicate that accuracy of adenocarcinoma subtyping based on small biopsy samples is influenced by tumor area. Our study also suggests that subtyping of acinar histology using biopsy specimen is particularly error-prone.

摘要

目的

肺腺癌具有异质性,由多种组织学亚型构成。已证实,确定主要组织学亚型(鳞屑状、乳头状、腺泡状或实性为主型)与基因异常及临床病理特征相关。尽管使用小活检样本进行亚型分类对于临床管理的个体化方法很重要,但关于切除标本与活检标本之间主要亚型的一致性数据有限。

材料与方法

我们比较了327例肺腺癌患者的切除标本和匹配活检标本中诊断出的主要亚型。研究了活检术前诊断的准确性以及影响与切除标本分析一致性的因素。

结果

在326例患者中的211例(66.0%)中,活检诊断的主要腺癌亚型与切除分析结果相符。总体而言,肿瘤面积较大(≥0.7平方毫米)的活检样本的一致性率显著高于肿瘤面积较小(<0.7平方毫米)的样本(分别为71.2%和60.7%;p=0.015)。在肿瘤面积较小的活检样本中,鳞屑状亚型的一致性率为77%,乳头状亚型为71%,实性亚型为60%,腺泡状亚型为40%。肿瘤面积较大的活检样本中,乳头状和实性亚型的一致性率较高(分别为88%和76%),但腺泡状亚型的一致性率仍然较低(37%)。

结论

目前的结果表明,基于小活检样本的腺癌亚型分类准确性受肿瘤面积影响。我们的研究还表明,使用活检标本对腺泡状组织学进行亚型分类特别容易出错。

相似文献

1
Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.影响肺腺癌活检标本与手术切除标本组织学亚型诊断一致性的因素。
Lung Cancer. 2016 Apr;94:1-6. doi: 10.1016/j.lungcan.2016.01.009. Epub 2016 Jan 22.
2
Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.采用国际肺癌研究协会/美国胸科学会/欧洲呼吸学会(IASLC/ATS/ERS)提议的分类方法对具有单一组织学模式的肺腺癌进行细胞病理学研究。
Cancer Cytopathol. 2015 May;123(5):306-17. doi: 10.1002/cncy.21532. Epub 2015 Mar 18.
3
Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.非优势型鳞屑样生长模式与浸润性肺腺癌的较好预后相关。
Lung Cancer. 2015 Dec;90(3):568-74. doi: 10.1016/j.lungcan.2015.10.014. Epub 2015 Oct 17.
4
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.提出的 IASLC/ATS/ERS 肺腺癌亚型在疾病预后和驱动基因改变相关性方面的实用性。
Lung Cancer. 2013 Sep;81(3):371-376. doi: 10.1016/j.lungcan.2013.06.012. Epub 2013 Jul 26.
5
Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.IASLC/ATS/ERS 新肺腺癌临床分期 IA 分类的预后价值。
Lung Cancer. 2015 Nov;90(2):199-204. doi: 10.1016/j.lungcan.2015.06.022. Epub 2015 Jul 2.
6
[Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].[表皮生长因子受体(EGFR)突变与肺腺癌病理分类及标本的关系]
Zhongguo Fei Ai Za Zhi. 2017 Jun 20;20(6):382-388. doi: 10.3779/j.issn.1009-3419.2017.06.03.
7
Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)肺腺癌亚型与正电子发射断层扫描中葡萄糖摄取的密切关联。
Lung Cancer. 2015 Jan;87(1):28-33. doi: 10.1016/j.lungcan.2014.11.010. Epub 2014 Nov 27.
8
Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?病理分期为IA期的肺腺癌的组织学优势是否会影响切除范围?
Gen Thorac Cardiovasc Surg. 2017 Sep;65(9):512-518. doi: 10.1007/s11748-017-0790-0. Epub 2017 Jun 7.
9
CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.CT 引导下经皮肺外周亚实性结节核心活检预测肺腺癌主要组织学和侵袭性亚型。
Ann Surg Oncol. 2020 Oct;27(11):4405-4412. doi: 10.1245/s10434-020-08511-9. Epub 2020 May 3.
10
Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)对Ⅰ期肺腺癌术中冰冻切片组织学亚型分类的准确性
Mod Pathol. 2015 Aug;28(8):1058-63. doi: 10.1038/modpathol.2015.71. Epub 2015 May 29.

引用本文的文献

1
Robotic-assisted bronchoscopy for histopathologic subtyping of primary lung adenocarcinoma.机器人辅助支气管镜检查用于原发性肺腺癌的组织病理学亚型诊断
Lung Cancer. 2025 Jul 28;207:108681. doi: 10.1016/j.lungcan.2025.108681.
2
Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution.从进化角度优化基于二代测序技术对多种肺癌的鉴别诊断
NPJ Precis Oncol. 2025 Jan 14;9(1):14. doi: 10.1038/s41698-024-00786-5.
3
Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance.表皮调节素在肺癌发生及治疗耐药中的作用
Cancers (Basel). 2024 Feb 7;16(4):710. doi: 10.3390/cancers16040710.
4
Preoperative F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma.术前F-FDG PET/CT及CT影像组学用于鉴别早期肺腺癌侵袭性组织病理学亚型
Comput Struct Biotechnol J. 2023 Nov 4;21:5601-5608. doi: 10.1016/j.csbj.2023.11.008. eCollection 2023.
5
Comparison of small biopsy and cytology specimens: Subtyping of pulmonary adenocarcinoma.小活检标本与细胞学标本的比较:肺腺癌的亚型分类
Cytojournal. 2023 Feb 8;20:5. doi: 10.25259/Cytojournal_45_2022. eCollection 2023.
6
Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.肺具有鳞屑样生长模式的腺癌侵袭性的预测因子。
Med Sci (Basel). 2022 Jun 22;10(3):34. doi: 10.3390/medsci10030034.
7
CT-Guided Percutaneous Core Needle Biopsy in Typing and Subtyping Lung Cancer: A Comparison to Surgery.CT 引导下经皮肺穿刺活检术在肺癌分型和亚型诊断中的应用:与手术的对比。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221086411. doi: 10.1177/15330338221086411.
8
Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.肺腺癌中固体组织学成分可能在 PD-L1 表达中起重要作用。
Thorac Cancer. 2022 Jan;13(1):24-30. doi: 10.1111/1759-7714.14209. Epub 2021 Nov 23.
9
New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma.国际肺癌研究协会(IASLC)病理学委员会关于晚期肺腺癌预后结果的新分级系统
Cancers (Basel). 2020 Nov 18;12(11):3426. doi: 10.3390/cancers12113426.
10
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.活检样本的形态学、免疫和遗传学特征与非鳞状非小细胞肺癌患者接受派姆单抗疗效的相关性。
J Cancer Res Clin Oncol. 2021 Apr;147(4):1227-1237. doi: 10.1007/s00432-020-03413-5. Epub 2020 Sep 30.